Biocryst Pharmaceuticals INC
SEC CIK 882796 · BCRX · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levin Alan G | Director | filed 2020 - 2026 |
| Milano Vincent | Director | filed 2021 - 2026 |
| Stonehouse Jon P | Director · President & CEO | filed 2007 - 2026 |
| Galson Steven K | Director | filed 2021 - 2026 |
| Frank Steven | Director | filed 2025 - 2026 |
| Milne Jill C. | Director | filed 2026 - 2026 |
| Sanders Machelle | Director | filed 2022 - 2026 |
| Heggie Theresa | Director | filed 2018 - 2026 |
| Mckee Amy E | Director | filed 2021 - 2026 |
| Hutson Nancy J | Director | filed 2012 - 2025 |
| Thackray Helen M. | Director · Chief R&D Officer | filed 2019 - 2025 |
| Aselage Steve | Director | filed 2019 - 2024 |
| Abercrombie George B | Director | filed 2011 - 2024 |
| LEE Kenneth B JR | Director | filed 2011 - 2023 |
| Ingram Robert Alexander | Director | filed 2015 - 2023 |
| Erck Stanley C | Director | filed 2008 - 2018 |
| Cohen Fred E | Director | filed 2013 - 2018 |
| Patel Sanj K | Director | filed 2015 - 2017 |
| Sanders Charles A | Director | filed 2009 - 2016 |
| Jensen Peder | Director | filed 2011 - 2014 |
| Higgins John L | Director | filed 2006 - 2012 |
| Horovitz Zola P | Director | filed 2006 - 2012 |
| Biggar Stephen R | Director | filed 2006 - 2011 |
| Seidenberg Beth C | Director | filed 2006 - 2010 |
| Featheringill William W | Director | filed 2006 - 2010 |
| Steer Randolph C | Director | filed 2006 - 2008 |
| Bennett J Claude | Director · President | filed 2006 - 2008 |
| Sherrill Joseph H JR | Director | filed 2006 - 2007 |
| Spencer William M III | Director | filed 2006 - 2007 |
| Bugg Charles E | Director · Chairman | filed 2006 - 2007 |
| Gordon Carl L | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Barnes Alane P | VP, General Counsel & Corp Sec | filed 2013 - 2026 |
| Menon Sandeep | Chief R&D Officer | filed 2026 - 2026 |
| Dullinger Ronald | Chief Commercial Officer | filed 2026 - 2026 |
| Gayer Charles K | Vice President and CCO | filed 2020 - 2025 |
| Ghias Babar | Chief Financial Officer | filed 2025 - 2025 |
| Doyle Anthony | Chief Financial Officer | filed 2020 - 2024 |
| Jones Michael L | Exec. Director, Finance - PAO | filed 2020 - 2022 |
| Babu Yarlagadda S | VP Drug Discovery | filed 2009 - 2022 |
| Sheridan William P | Senior VP - CMO | filed 2008 - 2022 |
| Sniecinski Megan | Chief Business Officer | filed 2019 - 2020 |
| Staab Thomas R II | Senior Vice President and CFO | filed 2011 - 2020 |
| Powell Lynne | Senior VP - CCO | filed 2015 - 2019 |
| Lowrey Robert S | Controller, PAO | filed 2011 - 2012 |
| Mccullough David | VP | filed 2007 - 2012 |
| Grant Stuart | SR VP & CFO | filed 2007 - 2011 |
| Mills Mike | Principal Accounting Officer | filed 2009 - 2010 |
| Darwin Michael A | Principal Accounting Officer | filed 2006 - 2008 |
| Alexander W James | SR. VP, Chief Medical Officer | filed 2006 - 2007 |
| Nugent Jonathan M | VP Corp Communications | filed 2006 - 2007 |
| Riggs Randall B | Senior VP Business Development | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.